from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
Why this ASX 200 blue-chip share could be an AI winner
-
Why are shares in this junior ASX gold explorer charging higher today?
-
REA shares rise as investors look past a rough year
-
Up 87% in a year, ASX 200 uranium stock drills into high-grade uranium